search
Back to results

Anterior Gastropexy vs. No Anterior Gastropexy for Paraesophageal Hernia Repair

Primary Purpose

Paraesophageal Hernia, Hiatal Hernia Large

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Anterior Gastropexy
Sponsored by
Clayton Petro
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Paraesophageal Hernia focused on measuring paraesophageal hernia, gastropexy, minimally invasive surgery

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 18+
  • Able to participate in follow-up
  • Symptomatic paraesophageal hernia
  • Paraesophageal hernia is at least 5 centimeters in height on upper GI study or endoscopy
  • Elective laparoscopic paraesophageal hernia repair (must begin laparoscopic, but may convert to open surgery if needed)
  • Crura must be reapproximated at time of surgery

Exclusion Criteria:

  • Previous operations of the esophagus or stomach
  • Emergent operation for acute gastric volvulus
  • Paraesophageal hernia repair with concurrent bariatric procedure or procedure to reduce stomach volume
  • Placement of gastrostomy tube

Sites / Locations

  • Cleveland Clinic Foundation

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Intervention 1 (Control)

Intervention 2 (Treatment)

Arm Description

No anterior gastropexy will be performed.

Anterior gastropexy will be performed.

Outcomes

Primary Outcome Measures

Paraesophageal Hernia Recurrence
Either radiographic evidence of hernia recurrence on an upper GI study or need for reoperation secondary to paraesophageal hernia recurrence

Secondary Outcome Measures

Mean Change from Baseline in GERD-HRQL Scores at 30 days and 1 year
The Gastroesophageal Reflux Disease Health-Related Quality of Life (GERD-HRQL) is a 10-item instrument to quantify symptom severity in gastroesophageal reflux disease. Scores on individual items are summed and may range from 0 to 50, with higher scores indicating greater severity of symptoms and worse quality of life. Additionally, there is a question about global satisfaction with quality of life, which may be answered as "satisfied," "neutral," or "dissatisfied." The percentages of these categories will be reported.
Mean Change from Baseline in Symptom Severity Measured by Visual Analog Scale at 30 days and 1 year
Eight symptoms that are potentially related to the presence of a paraesophageal hernia will be assessed on a scale ranging from 0 to 10, with higher scores indicating more significant impact on quality of life. Symptoms include regurgitation, chest pain, abdominal pain, nausea, vomiting, postprandial pain, cardiovascular, and pulmonary symptoms. Each symptom will be reported separately.

Full Information

First Posted
July 2, 2019
Last Updated
July 20, 2023
Sponsor
Clayton Petro
search

1. Study Identification

Unique Protocol Identification Number
NCT04007952
Brief Title
Anterior Gastropexy vs. No Anterior Gastropexy for Paraesophageal Hernia Repair
Official Title
Two-Armed Double-Blinded Registry-Based Randomized Control Trial Comparing Anterior Gastropexy to No Anterior Gastropexy for Paraesophageal Hernia Repair
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
June 26, 2019 (Actual)
Primary Completion Date
July 31, 2024 (Anticipated)
Study Completion Date
July 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Clayton Petro

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluates the effect of anterior gastropexy (one or more sutures fixing the stomach to the inner abdominal wall) on improving durability of paraesophageal hernia repair. Half of participants will receive anterior gastropexy, while the other half will not. The hypothesis is that anterior gastropexy will help to prevent paraesophageal hernias from recurring.
Detailed Description
Paraesophageal hernias are hernias in which the stomach and/or other abdominal organs herniate through the diaphragm into the chest. This abnormal anatomy can lead to acid reflux, trouble swallowing, and shortness of breath, and can also be a risk factor for surgical emergencies involving the stomach. For these reasons, the Society of American Gastrointestinal and Endoscopic Surgeons has strongly recommended that all symptomatic paraesophageal hernias be repaired. These repairs are technically challenging, and the best available evidence suggests that more than half of patients undergoing repair will have radiographic hernia recurrence at 5 years after surgery. There has been suggestion that use of anterior gastropexy - in which suture is used to affix the stomach to the anterior abdomen - may reduce recurrence rates. However, it is uncertain whether this data is reliable. While some surgeons use anterior gastropexy routinely because they believe it reduces recurrence, other surgeons do not use anterior gastropexy due to the concern that patients will have short-term pain at the suture site. This study aims to evaluate the effect of using anterior gastropexy on recurrence rates after paraesophageal hernia repair, compared to not using anterior gastropexy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Paraesophageal Hernia, Hiatal Hernia Large
Keywords
paraesophageal hernia, gastropexy, minimally invasive surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This will be a double-blinded, registry-based, randomized control trial comparing anterior gastropexy to no anterior gastropexy in paraesophageal hernia repair. This will be a two-arm trial with intervention 1: intervention 2 and control allocation ratio of 1:1.
Masking
ParticipantOutcomes Assessor
Masking Description
Participants will not be informed regarding the treatment that they received until they complete 1-year follow-up. Imaging will be reviewed at the end of the study period by surgeons who are blinded to treatment group.
Allocation
Randomized
Enrollment
240 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention 1 (Control)
Arm Type
No Intervention
Arm Description
No anterior gastropexy will be performed.
Arm Title
Intervention 2 (Treatment)
Arm Type
Experimental
Arm Description
Anterior gastropexy will be performed.
Intervention Type
Procedure
Intervention Name(s)
Anterior Gastropexy
Intervention Description
Two permanent sutures will be introduced into the abdomen and placed along the lesser curvature of the stomach. A suture passer will be used to grasp the ends of the sutures to externalize them at separate fascial punctures. At time of abdominal desufflation, the sutures will be tied and the incision closed per individual surgeon practice.
Primary Outcome Measure Information:
Title
Paraesophageal Hernia Recurrence
Description
Either radiographic evidence of hernia recurrence on an upper GI study or need for reoperation secondary to paraesophageal hernia recurrence
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Mean Change from Baseline in GERD-HRQL Scores at 30 days and 1 year
Description
The Gastroesophageal Reflux Disease Health-Related Quality of Life (GERD-HRQL) is a 10-item instrument to quantify symptom severity in gastroesophageal reflux disease. Scores on individual items are summed and may range from 0 to 50, with higher scores indicating greater severity of symptoms and worse quality of life. Additionally, there is a question about global satisfaction with quality of life, which may be answered as "satisfied," "neutral," or "dissatisfied." The percentages of these categories will be reported.
Time Frame
30 day follow up (15-45 days postop) and 1 year follow-up (6-18 months)
Title
Mean Change from Baseline in Symptom Severity Measured by Visual Analog Scale at 30 days and 1 year
Description
Eight symptoms that are potentially related to the presence of a paraesophageal hernia will be assessed on a scale ranging from 0 to 10, with higher scores indicating more significant impact on quality of life. Symptoms include regurgitation, chest pain, abdominal pain, nausea, vomiting, postprandial pain, cardiovascular, and pulmonary symptoms. Each symptom will be reported separately.
Time Frame
30 day follow up (15-45 days postop) and 1 year follow-up (6-18 months)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 18+ Able to participate in follow-up Symptomatic paraesophageal hernia Paraesophageal hernia is at least 5 centimeters in height on upper GI study or endoscopy Elective laparoscopic paraesophageal hernia repair (must begin laparoscopic, but may convert to open surgery if needed) Crura must be reapproximated at time of surgery Exclusion Criteria: Previous operations of the esophagus or stomach Emergent operation for acute gastric volvulus Paraesophageal hernia repair with concurrent bariatric procedure or procedure to reduce stomach volume Placement of gastrostomy tube
Facility Information:
Facility Name
Cleveland Clinic Foundation
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
12658421
Citation
Ponsky J, Rosen M, Fanning A, Malm J. Anterior gastropexy may reduce the recurrence rate after laparoscopic paraesophageal hernia repair. Surg Endosc. 2003 Jul;17(7):1036-41. doi: 10.1007/s00464-002-8765-2. Epub 2003 Mar 28.
Results Reference
background
PubMed Identifier
21715189
Citation
Oelschlager BK, Pellegrini CA, Hunter JG, Brunt ML, Soper NJ, Sheppard BC, Polissar NL, Neradilek MB, Mitsumori LM, Rohrmann CA, Swanstrom LL. Biologic prosthesis to prevent recurrence after laparoscopic paraesophageal hernia repair: long-term follow-up from a multicenter, prospective, randomized trial. J Am Coll Surg. 2011 Oct;213(4):461-8. doi: 10.1016/j.jamcollsurg.2011.05.017. Epub 2011 Jun 29. Erratum In: J Am Coll Surg. 2011 Dec;213(6):815.
Results Reference
background
PubMed Identifier
17439596
Citation
Velanovich V. The development of the GERD-HRQL symptom severity instrument. Dis Esophagus. 2007;20(2):130-4. doi: 10.1111/j.1442-2050.2007.00658.x.
Results Reference
background
PubMed Identifier
35907909
Citation
Blake KE, Zolin SJ, Tu C, Baier KF, Beffa LR, Alaedeen D, Krpata DM, Prabhu AS, Rosen MJ, Petro CC. Comparing anterior gastropexy to no anterior gastropexy for paraesophageal hernia repair: a study protocol for a randomized control trial. Trials. 2022 Jul 30;23(1):616. doi: 10.1186/s13063-022-06571-8.
Results Reference
derived
Links:
URL
https://www.sages.org/publications/guidelines/guidelines-for-the-management-of-hiatal-hernia/
Description
SAGES Guidelines for Management of Hiatal Hernia

Learn more about this trial

Anterior Gastropexy vs. No Anterior Gastropexy for Paraesophageal Hernia Repair

We'll reach out to this number within 24 hrs